BTMD 5.32 biote Corp.
| Range: | 3.654-8.44 | Vol Avg: | 178665 | Last Div: | 0 | Changes: | 0.01 |
| Beta: | 0.93 | Cap: | 0.29B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Wed Apr 28 2021 | Empoloyees: | 194 | ||
| CUSIP: | 090683103 | CIK: | 0001819253 | ISIN: | US0906831039 | Country: | US |
| CEO: | Ms. Teresa S. Weber | Website: | https://biote.com | ||||
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow